These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 3976924)
1. Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan. Pope HG; Jonas JM; Hudson JI; Kafka MP Am J Psychiatry; 1985 Apr; 142(4):491-2. PubMed ID: 3976924 [TBL] [Abstract][Full Text] [Related]
2. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor. Goff DC Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318 [TBL] [Abstract][Full Text] [Related]
4. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors. Kennedy SH J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307 [TBL] [Abstract][Full Text] [Related]
5. Myoclonus, hyperreflexia and diaphoresis in patients on phenelzine-tryptophan combination treatment. Levy AB; Bucher P; Votolato N Can J Psychiatry; 1985 Oct; 30(6):434-6. PubMed ID: 4063940 [TBL] [Abstract][Full Text] [Related]
6. Case report of a toxic reaction from a combination of tryptophan and phenelzine. Thomas JM; Rubin EH Am J Psychiatry; 1984 Feb; 141(2):281-3. PubMed ID: 6691495 [TBL] [Abstract][Full Text] [Related]
7. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review]. García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306 [TBL] [Abstract][Full Text] [Related]
8. Refractory depression treated with high doses of monoamine oxidase inhibitor. Guze BH; Baxter LR; Rego J J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984 [TBL] [Abstract][Full Text] [Related]
13. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression]. Nolen WA Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774 [TBL] [Abstract][Full Text] [Related]
14. Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study. Rabkin J; Quitkin F; Harrison W; Tricamo E; McGrath P J Clin Psychopharmacol; 1984 Oct; 4(5):270-8. PubMed ID: 6386898 [TBL] [Abstract][Full Text] [Related]
15. Severe daytime somnolence in patients treated with an MAOI. Teicher MH; Cohen BM; Baldessarini RJ; Cole JO Am J Psychiatry; 1988 Dec; 145(12):1552-6. PubMed ID: 3273886 [TBL] [Abstract][Full Text] [Related]
16. [Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors]. von Oefele K; Grohmann R; Hippius H; Rüther E Nervenarzt; 1988 Feb; 59(2):118-23. PubMed ID: 3362260 [No Abstract] [Full Text] [Related]
18. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression. Tulen JH; Volkers AC; van den Broek WW; Bruijn JA J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207 [No Abstract] [Full Text] [Related]
19. An open trial of MAO inhibitors in bulimia. Stewart JW; Walsh BT; Wright L; Roose SP; Glassman AH J Clin Psychiatry; 1984 May; 45(5):217-9. PubMed ID: 6373746 [TBL] [Abstract][Full Text] [Related]
20. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge]. Volz HP; Gleiter CH; Möller HJ Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]